Answers are grounded in this paper and cite their sources.
Selective inhibition of the late sodium current (INaL) represents a therapeutic target with potential relevance to a wide range of cardiac disorders, including angina and arrhythmias.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Antonio Zaza (2011) conducted a review in Cardiac disorders (angina and arrhythmias). Selective INaL (late sodium current) inhibition was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: